Publications by authors named "Sabrina Colarossi"

Claim this Profile
T
The impact of sensitive KIT D816V detection on recognition of indolent Systemic Mastocytosis.
Giovanna De Matteis, Roberta Zanotti, Sabrina Colarossi, Caterina De Benedittis, Andrès Garcia-Montero

Leuk Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders.
Omar Perbellini, Alberto Zamò, Sabrina Colarossi, Francesca Zampieri, Francesca Zoppi

Cytometry B Clin Cytom· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis.
Simona Soverini, Antonella Vitale, Angela Poerio, Alessandra Gnani, Sabrina Colarossi

Haematologica· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis.
Roberta Zanotti, Patrizia Bonadonna, Massimiliano Bonifacio, Anna Artuso, Donatella Schena, Sabrina Colarossi

Haematologica· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors.
Simona Soverini, Alessandra Gnani, Sabrina Colarossi, Fausto Castagnetti, Elisabetta Abruzzese

Blood· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP).
Ilaria Iacobucci, Clelia Tiziana Storlazzi, Daniela Cilloni, Annalisa Lonetti, Emanuela Ottaviani, Sabrina Colarossi

Blood· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.
Patrizia Bonadonna, Omar Perbellini, Giovanni Passalacqua, Beatrice Caruso, Sabrina Colarossi

J Allergy Clin Immunol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and Hymenoptera allergy.
Patrizia Bonadonna, Roberta Zanotti, Beatrice Caruso, Luca Castellani, Omar Perbellini, Sabrina Colarossi

J Allergy Clin Immunol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line treatment with dasatinib in patients resistant to imatinib can select novel inhibitor-specific BCR-ABL mutants in Ph+ ALL.
Simona Soverini, Giovanni Martinelli, Sabrina Colarossi, Alessandra Gnani, Michela Rondoni

Lancet Oncol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain.
Simona Soverini, Sabrina Colarossi, Alessandra Gnani, Fausto Castagnetti, Gianantonio Rosti

Haematologica· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia.
Simona Soverini, Sabrina Colarossi, Alessandra Gnani, Gianantonio Rosti, Fausto Castagnetti

Clin Cancer Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence or the emergence of a F317L BCR-ABL mutation may be associated with resistance to dasatinib in Philadelphia chromosome-positive leukemia.
Simona Soverini, Giovanni Martinelli, Sabrina Colarossi, Alessandra Gnani, Fausto Castagnetti

J Clin Oncol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis